Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for MCK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 1997. Start Trial.
Date Value
June 30, 2026 2.507B
March 31, 2026 2.647B
December 31, 2025 665.00M
September 30, 2025 790.00M
June 30, 2025 559.00M
March 31, 2025 272.00M
December 31, 2024 808.00M
September 30, 2024 1.46B
June 30, 2024 505.00M
March 31, 2024 637.00M
December 31, 2023 821.00M
September 30, 2023 782.00M
June 30, 2023 669.00M
March 31, 2023 118.00M
December 31, 2022 2.00B
September 30, 2022 448.00M
June 30, 2022 909.00M
March 31, 2022 1.484B
December 31, 2021 651.00M
September 30, 2021 224.00M
June 30, 2021 937.00M
March 31, 2021 207.00M
December 31, 2020 238.00M
September 30, 2020 230.00M
June 30, 2020 3.00M
Date Value
March 31, 2020 -21.00M
December 31, 2019 488.00M
September 30, 2019 695.00M
June 30, 2019 679.00M
March 31, 2019 222.00M
December 31, 2018 492.00M
September 30, 2018 565.00M
June 30, 2018 285.00M
March 31, 2018 740.00M
December 31, 2017 219.00M
September 30, 2017 345.00M
June 30, 2017 273.00M
March 31, 2017 220.00M
December 31, 2016 1.988B
September 30, 2016 -39.00M
June 30, 2016 22.00M
March 31, 2016 626.00M
December 31, 2015 330.00M
September 30, 2015 466.00M
June 30, 2015 67.00M
March 31, 2015 307.00M
December 31, 2014 -48.00M
September 30, 2014 -29.00M
June 30, 2014 68.00M
March 31, 2014 -25.00M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Cencora, Inc. 1.000B
Cardinal Health, Inc. 350.00M
Henry Schein, Inc. 199.00M
CVS Health Corp. -114.00M
Accendra Health, Inc. 0.00